Elacridar
Elacridar (GG918) is a potent, dual inhibitor of the efflux transporters P-glycoprotein and BCRP. It is widely used in pharmacological research to enhance the bioavailability and brain penetration of co-administered drugs in both in vitro and in vivo models.
Product Specifications
CAS Number
143664-11-3
Product Name Alternative
Cluster of differentiation 243, CD243, Breast cancer resistance protein, 786-O, ABCB1, ABCG2, BCRP, cancer, Inhibitor, inhibit, Multidrug resistance protein 1, MCF-7, MDR1, GW120918, GW-120918, GW 120918, GW 0918, GW0918, GW-0918, Elacridar, GG 918, GF120918, GF-120918, GF 120918, GG-918, GG918, sunitinib, P-glycoprotein, P-gp (P-glycoprotein), P-gp, Pgp
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.12% (May vary between batches)
Solubility
DMSO:7.86 mg/mL (13.95 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
COc1cc2CCN (CCc3ccc (NC (=O) c4cccc5c4[nH]c4c (OC) cccc4c5=O) cc3) Cc2cc1OC
Molecular Formula
C34H33N3O5
Molecular Weight
563.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1048913 Inquire
Recombinant Brucella abortus Glucose-6-phosphate isomerase (pgi), partial
Sign In for Pricing
View Details 
GTR15363921 1 Vial
Lentiviral human LPAR2 sgRNA gene knockout kit - Lentiviral human LPAR2 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details